Perfecting the Art of Cell Recovery

Advancells is a research oriented company that places a strong focus on therapeutic applications of Regenerative Medicine. We profile the company, as we look to discover more about innovative ways.

As one of the pioneers Stem Cell Company in India, the team at Advancells are passionate about the almost limitless potential of Human Stem Cells in providing a natural cure for any aliment that our body suffers from. With this belief, the firm strives to deliver technologies for the safe and effective treatment options to patients all over the world at the highest medical standards. Working closely alongside some of the best medical practitioners at world class medical centres across the globe, to provide the therapeutic solutions to their patients. The organisation is involved in several clinical trials and innovations across the world to consistently improve and further establish the safety and efficiency of their technology. All of this is on their journey towards the search for the “elixir of life”. Advancells are backed by doctors, stem cell experts and clinical research scientists to continually monitor and improve the effectiveness of the Quality Management System with excellence and Anti Ageing Therapies.

The vision for the company is Regenerative Medicine will soon be the centre of all kinds of therapeutic solutions applicable for a patient irrespective of the kind or stage of disease they would be suffering from. With the use of regenerative medicine protocols such as Human Stem Cells, combined with augmented and supplementary natural therapies, it will soon be the gold standard in keeping us healthy and young for a long period of time.

As for the organisations mission, they aim to be at the forefront of the vast research that is occurring across the globe within the field of Regenerative Medicine. The firm strives to consistently develop new, more efficient protocols and technologies that will be beneficial to the patients. Also, it will bring Regenerative Medicine to the centre of medical management of patients irrespective of the disease/ condition that they might be suffering from.

Moving the topic onto Advancells’ speciality, the company do not follow the practice of one size fits all, and thus a unique protocol us prepared for each patient; specially keeping in mind the best cell source, viable cell quantity and reinjection protocol. Advancells takes great pride in being transparent with our patients and as such, every cell is being produced in their laboratory is tested for viability, efficacy and safety, before being released for transplant. Every patient gets a certificate of analysist as a proof of their promise to them.

At Advancells, they have perfected the art of cell recovery and are able to consistently recover more than 94% cell count form various cell sources. This is up to 10 to 20 times more than what other dated technologies can perform. They have the ability to even expand the cell count via culture if the same is required in particular patients.

The overall aim for Advancells is be a global leader in providing every patient with a highly customised protocol for a 360 degree management of their disease/condition keeping Regenerative Medicine within the centre of therapeutic solution. The firm’s aim is to provide patients with a complete solution starting from preparation of the body to receive the transplant of the most viable, safe and efficient quantity of stem cells extracted from a source most suitable for the disease to the actual transplant, as well as post transplant preparations and follow up for the patient. Advancells aim to integrate their protocols with the conventional medicinal protocols, thereby providing the patient with the bet medical care, which is an accumulation of Medical and Surgical management along with Regenerative Medicine for an all-round management of the disease.

Looking ahead, Advancells hopes to continue the journey and the successes they achieved thus far, and will use it as a bench mark to obtain the endless possibilities and opportunities that are yet to come.